Zomedica Corp
NYSE American:ZOM

  • LAST PRICE
    0.1312
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.1313/ 15
  • Ask / Lots
    0.1331/ 691
  • Open / Previous Close
    --- / 0.1312
  • Day Range
    ---
  • 52 Week Range
    0.1170
    0.2285
  • Volume
    20,186

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Healthcare Facilities Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
ZOM
Zomedica Corp
128.6M
-2.1x
---
LDDD
Longduoduo Co Ltd
150.3M
119.7x
---
CDIX
Cardiff Lexington Corp
97.7M
0.8x
---
BDSX
Biodesix Inc
174.6M
-3.0x
---
CCEL
Cryo-Cell International Inc
66.9M
-7.7x
---
XGN
Exagen Inc
68.2M
-4.2x
---
As of 2024-11-22

Company Information

Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic Devices segment consists of Assisi and PulseVet products. Its TRUFORMA platform comprises point-of-care diagnostic products for disease states in dogs, cats and horses, providing assays for use at the point-of-care that provide reference lab accuracy. Its TRUVIEW platform consists of the TRUVIEW digital cystoscopy instrument providing microscopic images and related pathology services which enable practitioners to receive a pathologist interpretation of the images. The Assisi Loop platform includes a series of products that use targeted pulsed electromagnetic field (tPEMF) therapy.

Contact Information

Headquarters
100 Phoenix Drive, Suite 125ANN ARBOR, MI, United States 48108
Phone
734-369-2555
Fax
780-440-1377

Executives

Independent Chairman of the Board
Jeffrey Rowe
President
Larry Heaton
Chief Operating Officer
Anthony Blair
Vice President, General Manager, Chief Executive Officer of Pulse Veterinary Technologies, LLC
Adrian Lock
Chief Counsel, Company Secretary
Karen Dehaanfullerton

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$128.6M
Revenue (TTM)
$26.7M
Shares Outstanding
979.9M
Zomedica Corp does not pay a dividend.
Beta
1.06
EPS
$-0.06
Book Value
$0.24
P/E Ratio
-2.1x
Price/Sales (TTM)
4.8
Price/Cash Flow (TTM)
---
Operating Margin
-246.81%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.